Dr Reddys Laboratories (RDY) Total Debt Growth (5y) (2014 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Total Debt Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.81 Bn | 39.16 Bn | 2.15 Bn |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.90 Bn | 9.73 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.32 Bn | 479.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 997.70 Mn | 707.58 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 395.89 Mn | 354.64 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 179.21 Mn | 179.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.10% |
| Mar 31, 2026 | 17.94% |
| Dec 31, 2025 | 23.52% |
| Sep 30, 2025 | 10.45% |
| Jun 30, 2025 | 3.60% |
| Mar 31, 2025 | 16.58% |
| Dec 31, 2024 | 20.91% |
| Sep 30, 2024 | 9.28% |
| Jun 30, 2024 | -6.52% |
| Mar 31, 2024 | -14.17% |
| Dec 31, 2023 | -18.21% |
| Sep 30, 2023 | -27.38% |
| Jun 30, 2023 | -28.31% |
| Mar 31, 2023 | -33.11% |
| Dec 31, 2022 | -13.33% |
| Sep 30, 2022 | -23.61% |
| Jun 30, 2022 | -14.00% |
| Mar 31, 2022 | -20.58% |
| Dec 31, 2021 | -13.37% |
| Sep 30, 2021 | -14.40% |